beta-Endorphin release by angiotensin II: studies on the mechanism of action

Regul Pept. 1982 Jul;4(2):83-90. doi: 10.1016/0167-0115(82)90098-2.

Abstract

Blood-borne angiotensin II induces release of beta-endorphin-like immunoreactivity (beta-EI) from rat anterior pituitary gland. To study the mechanism of action we investigated in rats the effect of transection of subfornical organ efferent projections on angiotensin-induced beta-EI release in vivo and also the direct action of angiotensin II on beta-EI release from isolated adenohypophyses in vitro. (i) No effect of transection of subfornical organ efferents on the increase in plasma beta-EI following intravenous infusions of angiotensin II was found. (ii) When anterior pituitary quarters were continuously superfused in vitro, angiotensin II (1-10 nM) caused release of beta-EI into the superfusion medium in a dose-dependent manner. The stimulatory effect of angiotensin II (3 nM) was blocked by the receptor antagonist saralasin (300 nM). We conclude that beta-endorphin release by blood-borne angiotensin II, in contrast to other central effects of angiotensin, is not mediated by the subfornical organ; instead a direct action of angiotensin II on the adenohypophysis could be a mechanism of action responsible.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology*
  • Animals
  • Arginine Vasopressin / metabolism
  • Efferent Pathways / physiology
  • Endorphins / metabolism*
  • Male
  • Pituitary Gland, Anterior / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Time Factors
  • beta-Endorphin

Substances

  • Endorphins
  • Angiotensin II
  • Arginine Vasopressin
  • beta-Endorphin